Skip to McMaster Navigation Skip to Site Navigation Skip to main content
McMaster logo

Ontario Institute for Cancer Research (OICR) Funding Opportunity: Innovation to Implementation

Research Admin Offices:

  • HRS

Funding Type:


Opportunity Type:

  • Grant


Up to $100,000 per year is available, inclusive of overhead, for a maximum of two years. OICR funding is only tenable in Ontario. For-profit entities are not eligible to receive OICR funding.


  • Health Sciences



Internal Deadline:

January 12, 2023

Sponsor Deadline:

January 19, 2023

Additional Dates:

  • HRS Internal LOI Deadline - September 29, 2022
  • ROADS Internal LOI Deadline - October 6, 2022
  • Sponsor LOI Deadline - October 13, 2022
  • ROADS Internal Draft Application Deadline - January 5, 2023
  • HRS Internal Full Application Deadline - January 5, 2023
  • ROADS Internal Final Application Deadline - January 12, 2023
  • Sponsor Final Application Deadline - January 19, 2023


The Ontario Institute for Cancer Research (OICR) is inviting applications for the Innovation to Implementation (I2I) funding opportunity which is focused on overcoming barriers to the mobilization, or uptake, of knowledge required to facilitate adoption of research into policy or healthcare. OICR is committed to providing research funding to help support a sustainable health system that enables fair and equitable access to cancer interventions.

Additional Program Information:

RFA information session:

Sept. 20, 2022, 11 a.m.–12 p.m. (register here)

The FCRF program has limited the number of applications that may be submitted by McMaster to five. Applications submitted by November 18, 2022 will undergo an internal review process. Those selected will be forwarded to the FCRF by December 19, 2022 for further consideration by a joint Canada-France committee.


Examples of eligible studies include:

  • Studies that facilitate movement of research-generated knowledge to actual application of such knowledge in population health, screening or clinical practice settings
  • Studies that enable engagement of new users, including patients, along the translational continuum to advance the research into clinical settings
  • Studies that adapt a research tool for use in cancer prevention, clinical settings or clinical trials
  • Studies that conduct economic analysis or generate real-world evidence required to inform adoption of research into policy or routine healthcare
  • Studies evaluating the comparative real-world clinical- and cost-effectiveness of interventions
  • Knowledge translation activities that will advance the adoption of research into policy or routine healthcare


OICR invites applications from investigators at Ontario academic centres, hospital research institutes or other government research institutions. There is no limit to the number of applications investigators are eligible to submit as PI or Co-PI. OICR is focused on developing and supporting the next generation of cancer researchers and strongly encourages applicants to include early career investigators/clinicians as part of the project team. Further, teams should consider the inclusion of a physician and/or a biostatistician for relevant projects. This Request for Applications does not require previous OICR funding support in order to be eligible.


Additional Details 


Beatrice Fletcher, ROADS

If applying from the Faculty of Health Sciences, unless otherwise indicated, you no longer need to send documents to HRS Intake. Your first point of contact is your assigned Senior Grants Advisor.